Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Other News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Other News
 
Upcoming Event: International Conference on Biosimilars and Biologics
 
12-12-2019

Event: International Conference on Biosimilars and Biologics
Dates
: April 20 21, 2020
Venue: TBD, Dubai, UAE
Weblink: https://coalesceresearchgroup.com/conferences/biosimilars-biologics
Contact: Ms. Aisyah Atiqah
Tel: +1 718 543 9362
Email: biosimilars@coalescemeetings.com

Coalesce Research Group invites all pharmaceutical and Medical researchers, professionals, faculties and students the from across the globe to attend “International Conference on Biosimilars and Biologics” during April 20-21, 2020 at Dubai, UAE which includes keynote presentations from highly affiliated personalities, Oral talks, Poster presentations and Exhibitions.
 

ICBB 2020 focuses upon “The Present Scenario and Future Prospects of Biosimilars & Biologics”.  This biologics  meeting focuses on the trends which the biosimilars markets is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards Biosimilars, Pharmaceuticals and follow on biologics development and successful launching to the market.

Highlights/Sessions of the conference:

  • Current Challenges in Developing Biosimilars and Biologics
  • Emerging Biosimilars in Therapeutics
  •  Biosimilars Analytical Strategies
  • Regulatory Approach for Biosimilars
  • Globalization of Biosimilars
  • Biosimilars Role in Oncology and Gastroenterology
  • Biologics and Biosimilars in inflammatory bowel disease
  • Biosimilars vs Biologics
  • Biosimilars vs Generics
  • Biologics as therapeutics
  • Immunogenicity of Biosimilars
  • Intellectual Property Rights
  • Monoclonal Antibody and Fusion Protein Biosimilars
  • BCS and IVIVC Based Biowaivers
  • Biosimilar Companies and Market Analysis
  • Legal Issues and BPCI ACT
  • Biosimilars Research Pipeline
  • Bioequivalence Assessment
  • Biopharmaceuticals and Biotechnology
  • Current Trends in Pharmaceutical industry
  • Biosimilars in Rheumatology and Dermatology

Conference website: https://coalesceresearchgroup.com/conferences/biosimilars-biologics 

Conference performers list: https://coalesceresearchgroup.com/conferences/biosimilars-biologics/performers 

Conference registration: https://coalesceresearchgroup.com/conferences/biosimilars-biologics/registration

 
 
Relate News  
 
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links